Abstract 5734: Interleukin-1 signaling is required for HNSCC tumor response to cetuximab

Madelyn M Espinosa-Cotton; Rachel A Dahl; Elana Fertig; Isaac Jensen; Ayana J McLaren; Kenley Miller; Samuel N Rodman; Sandra Schmitz; Andrean L Simons

doi:10.1158/1538-7445.AM2018-5734

Back

Abstract

Peer reviewed

Abstract 5734: Interleukin-1 signaling is required for HNSCC tumor response to cetuximab

Madelyn M Espinosa-Cotton, Rachel A Dahl, Elana Fertig, Isaac Jensen, Ayana J McLaren, Kenley Miller, Samuel N Rodman, Sandra Schmitz and Andrean L Simons

Cancer research (Chicago, Ill.), Vol.78(13 Supplement), pp.5734-5734

07/01/2018

DOI: 10.1158/1538-7445.AM2018-5734

View Online

Abstract

abstract only

Details

Title: Subtitle: Abstract 5734: Interleukin-1 signaling is required for HNSCC tumor response to cetuximab
Creators: Madelyn M Espinosa-Cotton
Rachel A Dahl
Elana Fertig
Isaac Jensen
Ayana J McLaren
Kenley Miller
Samuel N Rodman
Sandra Schmitz
Andrean L Simons
Resource Type: Abstract
Publication Details: Cancer research (Chicago, Ill.), Vol.78(13 Supplement), pp.5734-5734
DOI: 10.1158/1538-7445.AM2018-5734
ISSN: 0008-5472
eISSN: 1538-7445
Language: English
Date published: 07/01/2018
Academic Unit: Emergency Medicine; Pathology; Surgery; Oral Pathology, Radiology and Medicine; Pharmaceutical Sciences and Experimental Therapeutics; Radiation Oncology
Record Identifier: 9984201419602771

Metrics

11 Record Views